斑块旋切术设备市场：依细分市场划分的规模、占有率、法规、偿付、程序、到2033年的预测

斑块旋切术是一种去除血管斑块的微创手术。斑块旋切术对于去除高度钙化的斑块特别有用。斑块切除术用于清除冠状动脉和周边血管的阻塞并恢復血流。斑块切除术也可以与血管成形术或支架置入术结合。

冠状动脉疾病（CAD）是指因心肌供血和供氧不足而导致冠状动脉狭窄。週边动脉疾病（PAD）的特征是下肢动脉粥状硬化斑块积聚，这会干扰正常血流并导致神经和组织损伤。这些疾病在已开发国家的高盛行率以及新的和改进的诊断方法的开发有助于提高使用微创手术（例如血管成形术、支架置入术和斑块切除术）的治疗率。这些治疗已成为 PAD 患者的首选治疗方法，取代了侵入性动脉绕道手术。

本报告深入探讨了全球旋切设备市场，包括竞争格局、SWOT 分析、到2033年的市场预测以及区域和国家趋势。

目录

目前市面上的旋切设备及竞争状况

• 对主要产业趋势的见解
• 2015年至2033年依细分市场划分的斑块旋切设备市场总收入及市场前景
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域与国家见解

• 旋切设备市场的 SWOT 分析
• 斑块切除设备市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技的监管状况

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Atherectomy is a minimally invasive procedure that removes plaque from vessels. Atherectomy is especially valuable in eliminating highly calcified plaque. Atherectomy procedure may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting.

Coronary Artery Disease (CAD) refers to narrowing of the coronary arteries due to inadequate supply of blood and oxygen to cardiac muscles. Peripheral artery disease (PAD) is characterized by the build-up of atherosclerotic plaque in the lower extremities, which disturbs normal blood flow and can cause nerve and tissue damage. The high prevalence of these disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty, stenting, and atherectomy. These procedures have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Atherectomy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Atherectomy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Atherectomy Devices market.
• Competitive dynamics insights and trends provided for Atherectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Atherectomy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Atherectomy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Atherectomy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Atherectomy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.